Sino Biopharmaceutical Stock Advances 4.8% in Hong Kong

Dow JonesJul 2 04:30 ET

We Ran A Stock Scan For Earnings Growth And Sino Biopharmaceutical (HKG:1177) Passed With Ease

Simply Wall StJun 28 20:03 ET

Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Genfleet Therapeutics (Shanghai), Inc. Class H (HK:2595)

TipRanksJun 28 05:01 ET · Ratings

Selected HKEX Announcements | Luk Fook Holdings reported net profit exceeding HK$2 billion for the last fiscal year; Topsports International's retail sales declined by more than 10% year-on-year in the last fiscal quarter.

① Luk Fook Holdings reported net profit exceeding HK$2 billion in the last fiscal year—what was its growth rate? ② Topsports International saw retail sales decline by more than 10% year-over-year in the last fiscal quarter—what factors contributed to this decline?

cls.cnJun 25 08:40 ET

Hong Kong-listed healthcare stocks emerge as a safe haven amid market weakness, with multiple indicators signaling that a bottoming opportunity is approaching.

① Has the Hong Kong-listed healthcare sector become a safe haven amid weak market conditions, and how strong has its recent performance been? ② Multiple indicators suggest a bottoming opportunity is approaching—what additional positive catalysts are expected this week?

cls.cnJun 24 02:52 ET

SINO BIOPHARMACEUT To Go Ex-Dividend On June 25th, 2026 With 0.12761 USD Dividend Per Share

Moomoo NewsJun 23 21:00 ET